Some recent analyst ratings include

• 10/24/2019-
  Acorda Therapeutics Inc (NASDAQ:ACOR) gets downgraded to Underweight by JPMorgan Chase & Co.
• 8/14/2019-
  Acorda Therapeutics Inc (NASDAQ:ACOR) gets downgraded to Neutral by HC Wainwright with a price target of $6.00
• 3/19/2019-
  Acorda Therapeutics Inc (NASDAQ:ACOR) had its Hold rating reiterated by Oppenheimer
• 1/7/2019-
  Acorda Therapeutics Inc (NASDAQ:ACOR) had its Buy rating reiterated by Cowen with a $30.00 price target

• On 2/22/2019 Lauren M Sabella, Insider, sold 761 with an average share price of $13.18 per share and the total transaction amounting to $10,029.98.
• On 1/30/2019 Scopia Capital Management Lp, Major Shareholder, sold 7,000 with an average share price of $16.01 per share and the total transaction amounting to $112,070.00.
• On 1/25/2019 Scopia Capital Management Lp, Major Shareholder, sold 11,001 with an average share price of $16.02 per share and the total transaction amounting to $176,236.02.
• On 1/23/2019 Scopia Capital Management Lp, Major Shareholder, sold 97,843 with an average share price of $16.01 per share and the total transaction amounting to $1,566,466.43.
• On 1/17/2019 Scopia Capital Management Lp, Major Shareholder, sold 100,000 with an average share price of $16.86 per share and the total transaction amounting to $1,686,000.00.
• On 1/15/2019 Scopia Capital Management Lp, Major Shareholder, sold 1,700 with an average share price of $16.60 per share and the total transaction amounting to $28,220.00.
• On 1/10/2019 Scopia Capital Management Lp, Major Shareholder, sold 162,491 with an average share price of $17.18 per share and the total transaction amounting to $2,791,595.38.

Recent Trading Activity for